Literature DB >> 11447134

Complete analysis of the glycosylation and disulfide bond pattern of human beta-hexosaminidase B by MALDI-MS.

C G Schuette1, J Weisgerber, K Sandhoff.   

Abstract

beta-hexosaminidase B is an enzyme that is involved in the degradation of glycolipids and glycans in the lysosome. Mutation in the HEXB gene lead to Sandhoff disease, a glycolipid storage disorder characterized by severe neurodegeneration. So far, little structural information on the protein is available. Here, the complete analysis of the disulfide bond pattern of the protein is described for the first time. Additionally, the structures of the N-glycans are analyzed for the native human protein and for recombinant protein expressed in SF21 cells. For the analysis of the disulfide bond structure, the protein was proteolytically digested and the resulting peptides were analyzed by MALDI-MS. The analysis revealed three disulfide bonds (C91-C137; C309-C360; C534-C551) and a free cysteine (C487). The analysis of the N-glycosylation was performed by tryptic digestion of the protein, isolation of glycopeptides by lectin chromatography and mass measurement before and after enzymatic deglycosylation. Carbohydrate structures were calculated from the mass difference between glycosylated and deglycosylated peptide. For beta-hexosaminidase B from human placenta, four N-glycans were identified and analyzed, whereas the recombinant protein expressed in SF21 cells carried only three glycans. In both cases the glycosylation belongs to the mannose-core- or high-mannose-type, and some carbohydrate structures are fucosylated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11447134     DOI: 10.1093/glycob/11.7.549

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  7 in total

1.  Crystal structure of β-hexosaminidase B in complex with pyrimethamine, a potential pharmacological chaperone.

Authors:  Katherine S Bateman; Maia M Cherney; Don J Mahuran; Michael Tropak; Michael N G James
Journal:  J Med Chem       Date:  2011-01-25       Impact factor: 7.446

2.  Metabolic profiling of Escherichia coli by ion mobility-mass spectrometry with MALDI ion source.

Authors:  Prabha Dwivedi; Geoffery Puzon; Maggie Tam; Denis Langlais; Shelley Jackson; Kimberly Kaplan; William F Siems; Albert J Schultz; Luying Xun; Amina Woods; Herbert H Hill
Journal:  J Mass Spectrom       Date:  2010-12       Impact factor: 1.982

3.  Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.

Authors:  Brian L Mark; Don J Mahuran; Maia M Cherney; Dalian Zhao; Spencer Knapp; Michael N G James
Journal:  J Mol Biol       Date:  2003-04-11       Impact factor: 5.469

4.  Human neutrophils secrete bioactive paucimannosidic proteins from azurophilic granules into pathogen-infected sputum.

Authors:  Morten Thaysen-Andersen; Vignesh Venkatakrishnan; Ian Loke; Christine Laurini; Simone Diestel; Benjamin L Parker; Nicolle H Packer
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

5.  Novel Mutations in Sandhoff Disease: A Molecular Analysis among Iranian Cohort of Infantile Patients.

Authors:  H Aryan; O Aryani; K Banihashemi; T Zaman; M Houshmand
Journal:  Iran J Public Health       Date:  2012-03-31       Impact factor: 1.429

6.  Phylogenetic analyses suggest multiple changes of substrate specificity within the glycosyl hydrolase 20 family.

Authors:  Jari Intra; Giulio Pavesi; David S Horner
Journal:  BMC Evol Biol       Date:  2008-07-22       Impact factor: 3.260

7.  Tay-Sachs disease mutations in HEXA target the α chain of hexosaminidase A to endoplasmic reticulum-associated degradation.

Authors:  Devin Dersh; Yuichiro Iwamoto; Yair Argon
Journal:  Mol Biol Cell       Date:  2016-09-28       Impact factor: 4.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.